Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PRKACA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
PRKACA is a gene implicated in neurodegeneration research. Key relationships include: therapeutic target, associated with, implicated in. Associated with Als, Diabetes, Hypertension. Connected to 59 entities in the SciDEX knowledge graph.
| Gene Symbol | PRKACA |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Molecular Weight | 40.6 kDa |
| Pathways | mTOR, mtor |
| GeneCards | PRKACA |
| Human Protein Atlas | PRKACA |
| Serine/threonine kinase | Phosphorylates serine and threonine residues |
| cAMP-dependent | Activity requires binding of cAMP to regulatory subunits |
| Heterotetrameric complex | R2C2 (2 regulatory + 2 catalytic subunits) |
| Substrate specificity | Broad substrate range including transcription factors, ion channels, and metabolic enzymes |
| Catalytic domain | Kinase domain in the C-terminal region |
| Nuclear localization | Can translocate to nucleus to phosphorylate transcription factors |
| Isoforms | Multiple catalytic subunit isoforms (Cα, Cβ, Cγ) |
| Autophosphorylation | Regulatory serine residues |
| Brain | High expression in hippocampus, cortex, cerebellum |
| Associated Diseases | Infection, Inflammation, Sepsis |
| Interactions | CAV1, AND, CPT1A, CAVEOLIN-1, Actin, Ubiquitin |
| KG Connections | 85 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
PRKACA["<b>PRKACA</b>"]
Diabetes{"Diabetes"}
PRKACA -->|"therapeutic target"| Diabetes
Obesity{"Obesity"}
PRKACA -->|"therapeutic target"| Obesity
Stroke{"Stroke"}
PRKACA -->|"therapeutic target"| Stroke
Als{"Als"}
PRKACA -->|"therapeutic target"| Als
Hypertension{"Hypertension"}
PRKACA -->|"therapeutic target"| Hypertension
Ischemia{"Ischemia"}
PRKACA -->|"therapeutic target"| Ischemia
Ms{"Ms"}
PRKACA -->|"therapeutic target"| Ms
AKT1["AKT1"]
PRKACA -->|"therapeutic target"| AKT1
TNF["TNF"]
PRKACA -->|"therapeutic target"| TNF
RAF1["RAF1"]
PRKACA -->|"therapeutic target"| RAF1
CHUK["CHUK"]
PRKACA -->|"therapeutic target"| CHUK
JUN["JUN"]
PRKACA -->|"therapeutic target"| JUN
JAK["JAK"]
JAK -->|"therapeutic target"| PRKACA
PI3K["PI3K"]
PI3K -->|"therapeutic target"| PRKACA
RELA["RELA"]
RELA -->|"therapeutic target"| PRKACA
PTGS2["PTGS2"]
PTGS2 -->|"therapeutic target"| PRKACA
style PRKACA fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Mapk | therapeutic_target | pathway | 0.70 |
| Diabetes | therapeutic_target | disease | 0.65 |
| Obesity | therapeutic_target | disease | 0.65 |
| Stroke | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Hypertension | therapeutic_target | disease | 0.65 |
| Ischemia | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Infection | associated_with | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Sepsis | associated_with | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Sepsis | therapeutic_target | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| ALS | inhibits | disease | 0.65 |
| Carcinoma | inhibits | disease | 0.65 |
| AKT1 | therapeutic_target | gene | 0.60 |
| TNF | therapeutic_target | gene | 0.60 |
| RAF1 | therapeutic_target | gene | 0.60 |
| CHUK | therapeutic_target | gene | 0.60 |
| JUN | therapeutic_target | gene | 0.60 |
| NLRC4 | associated_with | gene | 0.60 |
| CD4 | associated_with | gene | 0.60 |
| GCLM | associated_with | gene | 0.60 |
| MMP9 | therapeutic_target | gene | 0.60 |
| MMP14 | therapeutic_target | gene | 0.60 |
| EGFR | therapeutic_target | gene | 0.60 |
| CAV1 | inhibits | gene | 0.60 |
| Jak-Stat | therapeutic_target | pathway | 0.60 |
| Akt | therapeutic_target | pathway | 0.60 |
| Pi3K | therapeutic_target | pathway | 0.60 |
| AUTOPHAGY | associated_with | gene | 0.60 |
| Autophagy | associated_with | pathway | 0.60 |
| Cholesterol | associated_with | pathway | 0.60 |
| Immunotherapy | associated_with | pathway | 0.60 |
| Ferroptosis | associated_with | pathway | 0.60 |
| Oxidative Stress | associated_with | pathway | 0.60 |
| Immune Response | associated_with | pathway | 0.60 |
| Pyroptosis | associated_with | pathway | 0.60 |
| Apoptosis | therapeutic_target | pathway | 0.60 |
| Nf-Κb | therapeutic_target | pathway | 0.60 |
| NF-ΚB | therapeutic_target | gene | 0.60 |
| TNF-Α | therapeutic_target | gene | 0.60 |
| Lipid Metabolism | inhibits | pathway | 0.60 |
| Cholesterol | inhibits | pathway | 0.60 |
| AND | inhibits | gene | 0.60 |
| CPT1A | inhibits | gene | 0.60 |
| Actin | inhibits | protein | 0.60 |
| Ubiquitin | inhibits | protein | 0.60 |
| Ras | inhibits | protein | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PI3K | therapeutic_target | gene | 0.60 |
| RELA | therapeutic_target | gene | 0.60 |
| PTGS2 | therapeutic_target | gene | 0.60 |
| HTRA2 | associated_with | gene | 0.60 |
| AIM2 | associated_with | gene | 0.60 |
| GBM | associated_with | gene | 0.60 |
| CHMP7 | associated_with | gene | 0.60 |
| CD8 | associated_with | gene | 0.60 |
| MAP1LC3B | associated_with | gene | 0.60 |
| MMP14 | therapeutic_target | gene | 0.60 |
| TNF | therapeutic_target | gene | 0.60 |
| MAPK3 | therapeutic_target | gene | 0.60 |
| EGFR | therapeutic_target | gene | 0.60 |
| CAV1 | inhibits | gene | 0.60 |
| AKT1 | therapeutic_target | gene | 0.60 |
| CHUK | therapeutic_target | gene | 0.60 |
| RAF1 | therapeutic_target | gene | 0.60 |
| JUN | therapeutic_target | gene | 0.60 |
| JAK | therapeutic_target | gene | 0.60 |
| PYROPTOSIS | associated_with | gene | 0.60 |
| OXIDATIVE STRESS | associated_with | gene | 0.60 |
| FERROPTOSIS | associated_with | gene | 0.60 |
| INFLAMMATION | associated_with | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| APOPTOSIS | therapeutic_target | gene | 0.60 |
| NF-ΚB | therapeutic_target | gene | 0.60 |
| INFLAMMATION | therapeutic_target | gene | 0.60 |
| TNF-Α | therapeutic_target | gene | 0.60 |
| AND | therapeutic_target | gene | 0.60 |
| CPT1A | inhibits | gene | 0.60 |
| STROKE | therapeutic_target | gene | 0.60 |
| IL-17 | therapeutic_target | gene | 0.60 |
| MAPK | therapeutic_target | gene | 0.60 |
| CAV1 | activates | gene | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||